Excellent session on diversity, equity, and inclusion in our communities, profession and clinical trials. Particularly useful to learn about good mentorship. @opphd @DrAyalaLopez @LauraParnas, Dr. Lakshmi Ramanathan, Dr. Zahra Shajani-Yi
CAP inspection successful! It was an excellent and collegial endeavour where the intent of the process of peer review, education, and best practices was met. Thanks to the work of our lab professionals and thanks to our inspection team from Arkansas Children's and @HodaHagrass
Excellent review by Octavia Peck-Palmer @opphd and Amitava Dasgupta. I was especially interested in the sections on collections through CVC's and timing of TDM. https://t.co/ixlba47ind
Congratulations to the St. Jude Pharmaceutical Dept. on being named the 2021 recipient of the Warren E. Weaver/Richard P. Penna Award in the organization category by the Board of Pharmacy Specialties.
https://t.co/zKDieB7O8A @BPSweb
Lately I’ve been reading about lab-developed tests and this is an excellent recent review of laboratory regulations. The example LDTs included in the article provide useful context.
https://t.co/tE4Rfhl8I6
This is one of the best reviews I've read on laboratory-developed tests.
Laboratory-Developed Tests: A Legislative and Regulatory Review https://t.co/Oh0iyJpjRQ
This new CPIC guideline will make you rethink the data for OPRM1 and COMT and opioids. Our evidence review found that OPRM1 and COMT do not reach a level of evidence for clinical actionability for dosing opioids. Can’t wait for you to read it! https://t.co/TGo7lxRT9C @cpicpgx
Join us December 17 at 2:00 PM CST during #2020AACC for this session where we discuss active interventions by laboratorians that aim to improve patient care. With Zahra Shajani-Yi, PhD and @mcervinski
If attending #2020AACC and curious about pharmacogenomic testing our session moderated by Xin Yi, PhD from Houston Methodist is available on-demand. Also presenting Hyun Kim, PharmD from Boston Children’s, and @KellyCaudle13 from @StJudeResearch